Free Trial

Koninklijke Philips (PHG) Stock Forecast & Price Target

Koninklijke Philips logo
$26.49
+0.29 (+1.11%)
(As of 11/1/2024 ET)

Koninklijke Philips - Analysts' Recommendations and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Sell
0
Hold
4
Buy
1

Based on 5 Wall Street analysts who have issued ratings for Koninklijke Philips in the last 12 months, the stock has a consensus rating of "Hold." Out of the 5 analysts, 4 have given a hold rating, and 1 has given a buy rating for PHG.

Consensus Price Target

N/A

Get the Latest News and Ratings for PHG and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Koninklijke Philips and its competitors.

Sign Up

PHG Analyst Ratings Over Time

TypeCurrent Forecast
11/3/23 to 11/2/24
1 Month Ago
10/4/23 to 10/3/24
3 Months Ago
8/5/23 to 8/4/24
1 Year Ago
11/3/22 to 11/3/23
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
1 Buy rating(s)
1 Buy rating(s)
1 Buy rating(s)
2 Buy rating(s)
Hold
4 Hold rating(s)
3 Hold rating(s)
3 Hold rating(s)
3 Hold rating(s)
Sell
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
1 Sell rating(s)
Consensus Price TargetN/AN/AN/AN/A
Forecasted UpsideN/AN/AN/AN/A
Consensus Rating
Hold
Hold
Hold
Hold

PHG Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

PHG Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Koninklijke Philips Stock vs. The Competition

TypeKoninklijke PhilipsMedical CompaniesS&P 500
Consensus Rating Score
2.20
2.79
2.50
Consensus RatingHoldModerate BuyHold
Predicted UpsideN/A15,964.10% Upside10.61% Upside
News Sentiment Rating
Neutral News

See Recent PHG News
Neutral News
Positive News
DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
10/29/2024Jefferies Financial Group
2 of 5 stars
 UpgradeUnderperform ➝ Hold
5/13/2024Sanford C. Bernstein
3 of 5 stars
 UpgradeMarket Perform ➝ Outperform
5/7/2024BNP Paribas
3 of 5 stars
 UpgradeUnderperform ➝ Neutral
4/30/2024UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 UpgradeSell ➝ Neutral
4/30/2024JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 UpgradeUnderweight ➝ Neutral
7/12/2023The Goldman Sachs Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageBuy
7/7/2023Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost Target€19.00
4/25/2023Societe Generale
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 UpgradeSell ➝ Hold
1/17/2023Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetEqual Weight ➝ Equal Weight€17.00 ➝ €16.00
1/10/2023Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetOverweight ➝ Overweight€19.00 ➝ €18.50

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Saturday at 06:34 AM ET.


Should I Buy Koninklijke Philips Stock? PHG Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Tuesday, October 22, 2024. Please send any questions or comments about these Koninklijke Philips pros and cons to contact@marketbeat.com.

Koninklijke Philips
Bull Case

green Wall Street bull icon

Here are some ways that investors could benefit from investing in Koninklijke Philips:

  • Koninklijke Philips has shown consistent growth in revenue and earnings, indicating a strong financial performance.
  • The company's recent positive earnings report, with $0.32 earnings per share and $4.80 billion in revenue, demonstrates financial stability.
  • With a market capitalization of $30.75 billion, Koninklijke Philips is a significant player in the technology sector, offering stability and potential growth.
  • The stock price of Koninklijke Philips has been steadily increasing, reaching $32.71, which may indicate positive investor sentiment and potential for further gains.
  • Analysts predict that Koninklijke Philips will post 1.57 EPS for the current fiscal year, suggesting future profitability and growth potential.

Koninklijke Philips
Bear Case

red Wall Street bear icon

Investors should be bearish about investing in Koninklijke Philips for these reasons:

  • Despite recent positive performance, Koninklijke Philips has a negative net margin of 2.35%, indicating potential financial challenges.
  • The company's P/E ratio of -34.08 may raise concerns about overvaluation or market expectations that could impact stock performance.
  • Koninklijke Philips has a debt-to-equity ratio of 0.60, which suggests a moderate level of financial leverage that could affect future financial health.
  • The company's beta of 0.73 indicates lower volatility compared to the market average, potentially limiting short-term trading opportunities for investors.
  • While Koninklijke Philips has shown growth, competition in the technology sector is intense, posing challenges for sustained market share and profitability.

PHG Forecast - Frequently Asked Questions

5 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Koninklijke Philips in the last year. There are currently 4 hold ratings and 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" PHG shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in PHG, but not buy additional shares or sell existing shares.

According to analysts, Koninklijke Philips's stock has a predicted downside of -100.00% based on their 12-month stock forecasts.

Over the previous 90 days, Koninklijke Philips's stock had 1 upgrade by analysts.

Koninklijke Philips has been rated by research analysts at Jefferies Financial Group in the past 90 days.

Analysts like Koninklijke Philips less than other "medical" companies. The consensus rating for Koninklijke Philips is Hold while the average consensus rating for "medical" companies is Moderate Buy. Learn more on how PHG compares to other companies.


This page (NYSE:PHG) was last updated on 11/2/2024 by MarketBeat.com Staff
From Our Partners